Invariant NKT cells limit activation of autoreactive CD1d-positive B cells
Open Access
- 3 May 2010
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 207 (5), 943-952
- https://doi.org/10.1084/jem.20091314
Abstract
Faulty activation of autoreactive B cells is a hallmark of autoimmune diseases like systemic lupus erythematosus (SLE). An important feature restricting activation of autoreactive B cells is efficient removal of apoptotic material. Mounting evidence also connects a primary defect in invariant natural killer T (iNKT) cells to autoimmune disease development. However, exactly how this unconventional T cell subset is involved remains to be defined. Here, we identify a suppressive role for iNKT cells in a model where autoantibody production is triggered by an increased load of circulating apoptotic cells, resembling the situation in SLE patients. Absence or reduction of iNKT cells as well as absence of CD1d-expression on B cells, needed for direct iNKT-B cell interaction, leads to increased autoreactive B cell activation and symptoms of disease. The suppression mediated by the iNKT cells is observed before B cell entry into germinal centers and can be rescued by transferring iNKT cells to deficient mice. This links iNKT cells to handling of dying cells and identifies a novel peripheral tolerance checkpoint relevant for autoimmune disease. Thus, these observations connect two clinical observations in SLE patients previously considered to be unrelated and define a new target for immunotherapy.This publication has 41 references indexed in Scilit:
- Immunogenic and tolerogenic cell deathNature Reviews Immunology, 2009
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancerBlood, 2008
- NK T cells provide lipid antigen-specific cognate help for B cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell helpin vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- Reduced proportions of NKT cells are present in the relatives of lupus patients and are associated with autoimmunityArthritis Research & Therapy, 2008
- Natural killer T cells and innate immune B cells from lupus‐prone NZB/W mice interact to generate IgM and IgG autoantibodiesEuropean Journal of Immunology, 2007
- Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupusThe Journal of Experimental Medicine, 2007
- Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus modelArthritis & Rheumatism, 2007
- Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against DiabetesThe Journal of Experimental Medicine, 1998